Showing results (1351-1360 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|June 24, 2026
Primary adherence to medications for the treatment of major depressive disorder: A descriptive study using real-world dataAnn Von Holle, Jeff T Mohl, Rachael B Zuckerman, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2021
For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reportsJason Shafrin, Syvart Dennen, Priti Pednekar, et al.Journal of Managed Care & Specialty Pharmacy|November 24, 2021
Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspectiveMarjolaine Gauthier-Loiselle, Steven N Michalopoulos, Martin Cloutier, et al.Journal of Managed Care & Specialty Pharmacy|September 28, 2021
Using latent class and quantum models to value equity in health care: a tale of 2 storiesSurachat NgorsurachesJournal of Managed Care & Specialty Pharmacy|August 2, 2021
Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policyMinghui Li, Bo Cai, Patrick Mauldin, et al.Journal of Managed Care & Specialty Pharmacy|May 17, 2021
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United StatesStewart J Tepper, Juanzhi Fang, Lujia Zhou, et al.Journal of Managed Care & Specialty Pharmacy|May 6, 2026
Improving adherence to guideline-based lipid-lowering therapy in people with hyperlipidemia using a targeted educational outreach approachErin Conley, Susanna Chang, Laney K Jones, et al.Journal of Managed Care & Specialty Pharmacy|August 27, 2026
AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depressionBridget Flavin, Gary Small, Charles Dragovich, et al.Journal of Managed Care & Specialty Pharmacy|July 21, 2026
Real-time continuous glucose monitoring related to reductions in inpatient and emergency department encounters and their associated costs among non-insulin-treated people with type 2 diabetesKatia Hannah, Poorva Nemlekar, Gregory J NormanJournal of Managed Care & Specialty Pharmacy|September 11, 2026
Economic advantage of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: A cost-per-responder evaluationSantosh Gautam, Laura Morrison, Philippe Thompson-Leduc, et al.Pageof 185